Vaccination Updates

Everyone Ages 18 and Older Should Get a Booster Shot

You may choose which COVID-19 vaccine you receive as a booster shot. Some people may prefer the vaccine type that they originally received, and others may prefer to get a different booster. CDC’s recommendations now allow for this type of mix and match dosing for booster shots. Learn more…

Who Is Eligible for a COVID-19 Vaccine Booster Shot?

COVID-19 Vaccine booster shots are available for the following Pfizer-BioNTech vaccine recipients who completed their initial series at least 6 months ago.

Vaccine Tracker

MAP: Covid-19 vaccination tracker across the U.S. The tracker is updated daily by the CDC.

Medicare and the COVID Vaccine

You pay nothing for this vaccine. A COVID-19 vaccine helps reduce the risk of illness from COVID-19 by working with the body’s natural defenses to safely develop protection (immunity) to the virus.

What to Expect after Getting a COVID-19 Vaccine

COVID-19 vaccination will help protect you from getting COVID-19. You may have some side effects, which are normal signs that your body is building protection. These side effects may affect your ability to do daily activities, but they should go away in a few days.

Ensuring the Safety of COVID-19 Vaccines in the United States

The U.S. vaccine safety system ensures that all vaccines are as safe as possible. Safety is a top priority while federal partners work to make this and other COVID-19 vaccines available.

Latest News

Statement from President Biden on Omicron

As a precautionary measure until we have more information, I am ordering additional air travel restrictions from South Africa and seven other countries. These new restrictions will take effect on November 29. As we move forward, we will continue to be guided by what the science and my medical team advises.

Study of COVID Vaccine Boosters Suggests Moderna or Pfizer Works Best

The findings show that getting a J&J boost after the initial one-shot immunization is “not as good” as receiving one of other vaccines as a booster.

Pfizer Covid-19 Vaccine: FDA Authorizes Booster Dose for People 65 and Up

The US Food and Drug Administration said Wednesday it would grant emergency use authorization for a booster dose of Pfizer’s Covid-19 vaccine in people 65 and older, people at high risk of severe disease and people whose jobs put them at risk of infection.

Fauci Says Data from NIH’s Mix-and-Match Covid Vaccine Booster Trials Will Soon Be Ready

Data on Johnson & Johnson’s mix-and-match study could be ready within a week, while Pfizer’s trial might be completed by mid-October. Moderna’s mix-and-match study data is already available.

CDC Says Vaccinated People Don’t Need to Wear Masks in Most Indoor Settings

Clinical trials showed that the vaccines are incredibly effective at preventing COVID-19, and real-world evidence confirmed those findings.

Biden to Unveil Vaccination Plan This Week

The plan will serve as a roadmap to quickly vaccinating millions of Americans amid frustration over the slow rollout of the initial doses.

Fauci Says U.S. Needs More Time To ‘Catch Up’ On Vaccine Rollout

Health experts warned that the coronavirus pandemic would get worse before it got better. And that is happening. December was the deadliest month of the pandemic in the United States. The vaccines have made people optimistic, but the process has been slow.

Moderna CEO Says COVID-19 Vaccine Protection May Last Years

While speaking at a virtual event by Oddo BHF, a financial service group, Moderna CEO Stephane Bancel said the once-believed “nightmare scenario” that the vaccine won’t work is now out the window. “We believe there will be protection potentially for a couple of years,” Bancel said.

FDA Statement on Following the Authorized Dosing Schedules for COVID-19 Vaccines

Two different mRNA vaccines have now shown remarkable effectiveness of about 95% in preventing COVID-19 disease in adults.

Moderna Increases Minimum 2021 Covid Vaccine Production by 20% to 600 Million Doses

Moderna is increasing its Covid-19 vaccine production this year, upping the minimum number of doses it expects to make by 20% to 600 million, the company announced Monday.